Breaking News

ThinkCyte Introduces New Cell Analysis Platform

The full commercial rollout of VisionCyte will occur in 2025.

Author Image

By: Charlie Sternberg

Associate Editor

VisionCyte.

ThinkCyte, a biotechnology company pioneering novel artificial intelligence (AI)-based cell analysis and sorting instruments, has announced the pre-commercial launch of its new cell analysis platform, VisionCyte—extending its product portfolio of life science research platforms beyond VisionSort, the company’s flagship product launched in 2023. The VisionCyte platform leverages high-resolution morphological profiling, high-throughput capabilities, and advanced AI analysis to uncover nov...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters